Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Male Type 1 Diabetes
NCT02211742Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Aug 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Dapagliflozin with Placebo (2 arms). Primary endpoints: Fasting Glucose Homeostasis at Day 3 and Postprandial Glucose Homeostasis at Day 3. Started Aug 2014; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02211742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211742.